Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Physiol Res ; 63(1): 1-11, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24182344

RESUMO

In this study, we focused on an analysis of biguanides effects on mitochondrial enzyme activities, mitochondrial membrane potential and membrane permeability transition pore function. We used phenformin, which is more efficient than metformin, and evaluated its effect on rat liver mitochondria and isolated hepatocytes. In contrast to previously published data, we found that phenformin, after a 5 min pre-incubation, dose-dependently inhibits not only mitochondrial complex I but also complex II and IV activity in isolated mitochondria. The enzymes complexes inhibition is paralleled by the decreased respiratory control index and mitochondrial membrane potential. Direct measurements of mitochondrial swelling revealed that phenformin increases the resistance of the permeability transition pore to Ca(2+) ions. Our data might be in agreement with the hypothesis of Schäfer (1976) that binding of biguanides to membrane phospholipids alters membrane properties in a non-specific manner and, subsequently, different enzyme activities are modified via lipid phase. However, our measurements of anisotropy of fluorescence of hydrophobic membrane probe diphenylhexatriene have not shown a measurable effect of membrane fluidity with the 1 mM concentration of phenformin that strongly inhibited complex I activity. Our data therefore suggest that biguanides could be considered as agents with high efficacy but low specifity.


Assuntos
Biguanidas/farmacologia , Complexo II de Transporte de Elétrons/fisiologia , Complexo IV da Cadeia de Transporte de Elétrons/fisiologia , Complexo I de Transporte de Elétrons/fisiologia , Mitocôndrias Hepáticas/enzimologia , Animais , Relação Dose-Resposta a Droga , Complexo I de Transporte de Elétrons/antagonistas & inibidores , Complexo II de Transporte de Elétrons/antagonistas & inibidores , Complexo IV da Cadeia de Transporte de Elétrons/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Masculino , Metformina/farmacologia , Mitocôndrias Hepáticas/efeitos dos fármacos , Fenformin/farmacologia , Ratos , Ratos Wistar
2.
Physiol Res ; 61(Suppl 2): S67-76, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23130905

RESUMO

Autophagy-lysosomal pathway is a cellular mechanism ensuring degradation of various macromolecules like proteins or triacylglycerols (TAG). Its disruption is related to many pathological states, including liver steatosis. We compared the effect of short- and long-established steatosis on the intensity of autophagy-lysosomal pathway in rat liver. The experiments were carried out on 3-month old Wistar rats fed standard (SD) or high-fat diet for 2 (HF-2) or 10 (HF-10) weeks. HF diet administered animals accumulated an increased amount of TAG in the liver (HF-2->HF-10). Autophagy flux was up-regulated in HF-2 group but nearly inhibited after 10 weeks of HF administration. The expression of autophagy related genes was up-regulated in HF-2 but normal in HF-10. In contrast, total activities of two lysosomal enzymes, lysosomal lipase (LAL) and acid phosphatase, were unaffected in HF-2 but significantly increased in HF-10 groups. mRNA expression of lysosomal enzymes was not affected by the diet. We conclude that in a state of metabolic unbalance (steatosis), autophagy machinery and lysosomal enzymes expression are regulated independently. The accumulation of TAG in the liver is associated with the increase of total LAL activity and protein expression. In contrast, the autophagy response is bi-phasic and after rapid increase it is significantly diminished. This may represent an adaptive mechanism that counteracts the excessive degradation of substrate, i.e. TAG, and eliminate over-production of potentially hazardous lipid-degradation intermediates.


Assuntos
Autofagia , Dieta Hiperlipídica , Fígado/metabolismo , Lisossomos/metabolismo , Animais , Gorduras na Dieta/farmacologia , Fígado Gorduroso/metabolismo , Fígado Gorduroso/patologia , Lipólise , Lisossomos/enzimologia , Masculino , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Fatores de Tempo , Triglicerídeos/metabolismo
3.
Physiol Res ; 61(3): 287-97, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22480422

RESUMO

We present data supporting the hypothesis that the lysosomal-autophagy pathway is involved in the degradation of intracellular triacylglycerols in the liver. In primary hepatocytes cultivated in the absence of exogenous fatty acids (FFA), both inhibition of autophagy flux (asparagine) or lysosomal activity (chloroquine) decreased secretion of VLDL (very low density lipoproteins) and formation of FFA oxidative products while the stimulation of autophagy by rapamycine increased some of these parameters. Effect of rapamycine was completely abolished by inactivation of lysosomes. Similarly, when autophagic activity was influenced by cultivating the hepatocytes in "starving" (amino-acid poor medium) or "fed" (serum-supplemented medium) conditions, VLDL secretion and FFA oxidation mirrored the changes in autophagy being higher in starvation and lower in fed state. Autophagy inhibition as well as lysosomal inactivation depressed FFA and DAG (diacylglycerol) formation in liver slices in vitro. In vivo, intensity of lysosomal lipid degradation depends on the formation of autophagolysosomes, i.e. structures bringing the substrate for degradation and lysosomal enzymes into contact. We demonstrated that lysosomal lipase (LAL) activity in liver autophagolysosomal fraction was up-regulated in fasting and down-regulated in fed state together with the increased translocation of LAL and LAMP2 proteins from lysosomal pool to this fraction. Changes in autophagy intensity (LC3-II/LC3-I ratio) followed a similar pattern.


Assuntos
Autofagia , Hepatócitos/metabolismo , Lipólise , Fígado/metabolismo , Lisossomos/metabolismo , Triglicerídeos/metabolismo , Animais , Asparagina/farmacologia , Autofagia/efeitos dos fármacos , Células Cultivadas , Cloroquina/farmacologia , Diglicerídeos/metabolismo , Ácidos Graxos não Esterificados/metabolismo , Hepatócitos/efeitos dos fármacos , Hepatócitos/patologia , Lipoproteínas VLDL/metabolismo , Fígado/efeitos dos fármacos , Fígado/patologia , Proteína 2 de Membrana Associada ao Lisossomo/metabolismo , Lisossomos/efeitos dos fármacos , Lisossomos/patologia , Masculino , Proteínas Associadas aos Microtúbulos/metabolismo , Oxirredução , Ratos , Ratos Wistar , Sirolimo/farmacologia , Esterol Esterase/metabolismo
4.
Physiol Res ; 60(5): 835-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21812516

RESUMO

Metformin is widely used in the treatment of Type 2 diabetes, however, mechanisms of its antihyperglycemic effect were not yet fully elucidated. Complex I of mitochondrial respiration chain is considered as one of the possible targets of metformin action. In this paper, we present data indicating that the inhibitory effect of metformin can be tested also in liver homogenate. Contrary to previous findings on hepatocytes or mitochondria under our experimental conditions, lower metformin concentrations and shorter time of preincubation give significant inhibitory effects. These conditions enable to study the mechanism of the inhibitory effect of metformin in small samples of biological material (50-100 mg wet weight) and compare more experimental groups of animals because isolation of mitochonria is unnecessary.


Assuntos
Fígado/efeitos dos fármacos , Fígado/enzimologia , Metformina/farmacologia , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/enzimologia , NADP/metabolismo , Oxigênio/metabolismo , Animais , Masculino , Oxirredução/efeitos dos fármacos , Ratos , Ratos Wistar
5.
Folia Biol (Praha) ; 56(4): 173-82, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20974050

RESUMO

This study was designed to test the role of liver lipases in the degradation of liver triacylglycerols (TAG) and to determine the effect of dietary induced TAG accumulation in the liver on regulation of their lipolysis. Male Wistar rats were administered high-fat or high-sucrose diet for two weeks. Individual lipases (HL; TGH; LAL) were identified according to their different pH optimum. Administration of both diets resulted in liver TAG accumulation (HFD >>> HSD). The only lipase capable to hydrolyse intracellular TAG was LAL. On standard diet, LAL activity towards both endogenous and exogenous substrates was up-regulated in fasting and downregulated in fed state. The intensity of autophagy determined according to the LC3-II/LC3-I protein ratio followed a similar pattern. HFD led to an increase of this ratio, elevation of LAL activity in phagolysosomal fraction and abolishment of fasting/fed-dependent differences. LAL activity significantly correlated with ketogenesis in all groups (r = 0.86; P < 0.01). In the HFD group, we determined the enhanced release of lysosomal enzymes (glucuronidase, LAL) into the cytosol. Dgat-1 expression was up-regulated in HFD- and HSD-fed groups, which indicates increased FFA esterification. We demonstrated that LAL is a dominant enzyme involved in degradation of intracellular TAG in the liver and its translocation into the fraction of active (auto)phagolysosomes is stimulated by diet-induced TAG accumulation. Autophagy is stimulated under the same conditions as LAL and may represent the mechanism ensuring the substrate enzyme contact in autophagolysosomes. In fatty liver, destabilization of (auto)phagolysosomes may contribute to their susceptibility to further stress factors.


Assuntos
Autofagia/fisiologia , Fígado/metabolismo , Lisossomos/fisiologia , Esterol Esterase/metabolismo , Triglicerídeos/metabolismo , Animais , Gorduras na Dieta/administração & dosagem , Gorduras na Dieta/farmacologia , Sacarose Alimentar/administração & dosagem , Sacarose Alimentar/farmacologia , Fígado Gorduroso/metabolismo , Fígado/efeitos dos fármacos , Fígado/enzimologia , Lisossomos/enzimologia , Masculino , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...